Join David Nascimento-Brooks, mba at the Outsourced Pharma Large Molecule Capacity Update to explore how Catalent’s mammalian cell line engineering and biomanufacturing capabilities, utilizing single-use systems, provide the flexibility and scalability needed to support their customers' growth. Reserve your spot for the virtual event on April 22nd: https://lnkd.in/esjjQant
Outsourced Pharma’s Post
More from this author
-
What Takeda's Award-Winning Facility Can Teach You About Outsourcing, The Importance Of Primary And Secondary Drying, and More
-
Technologies Propelling GLP-1 Analogues, Updates On BIOSECURE Act And Other Supply-Chain Concerns, and More
-
Will Trump Reverse The Tide On CDMO Asia Expansion, Why You Should Consider AI In Analytical Instrument Qualification, and More